Mirum Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Mirum Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $289K, a 10.3% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.08M, a 18.4% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $911K, a 5.44% increase from 2021.
  • Mirum Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $864K, a 50% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.08M +$168K +18.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $911K +$47K +5.44% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $864K +$288K +50% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $576K +$406K +239% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $170K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.